22 Humanized NOG-EXL mice exhibit improved overall survival and less severe myeloid cell activation relative to humanized NSG-SGM3 mice

• Zev Binder,
• Charles-Antoine Assenmacher,
• Elinor Willis,
• Enrico Radaelli,
• Jillian Verrelle,
• Esha Banerjee,
• James C Tarrant,
• Nicolas Skuli,
• Moriah L Jacobson

Affiliations

Zev Binder

University of Pennsylvania, Philadelphia, PA, USA

Charles-Antoine Assenmacher

2Comparative Pathology Core, Department of Pathobiology, School of Veterinary Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Elinor Willis

1University of Pennsylvania, Philadelphia, PA, USA

Enrico Radaelli

4Comparative Pathology Core, Department of Pathobiology, School of Veterinary Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Jillian Verrelle

1University of Pennsylvania, Philadelphia, PA, USA

Esha Banerjee

1University of Pennsylvania, Philadelphia, PA, USA

James C Tarrant

3GlaxoSmithKline, Collegeville, PA, USA

Nicolas Skuli

1University of Pennsylvania, Philadelphia, PA, USA

Moriah L Jacobson

4Taconic Biosciences, Rockville, MD, USA